107 related articles for article (PubMed ID: 30810839)
1. Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma.
Cheng X; Yin H; Fu J; Chen C; An J; Guan J; Duan R; Li H; Shen H
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1027-1035. PubMed ID: 30810839
[TBL] [Abstract][Full Text] [Related]
2. Genomic architecture of lung cancers.
Fernandez-Cuesta L; McKay JD
Curr Opin Oncol; 2016 Jan; 28(1):52-7. PubMed ID: 26569422
[TBL] [Abstract][Full Text] [Related]
3. Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden.
Gorlov IP; Gorlova OY; Tsavachidis S; Amos CI
Sci Rep; 2024 Jun; 14(1):12732. PubMed ID: 38831004
[TBL] [Abstract][Full Text] [Related]
4. A novel transformer-based aggregation model for predicting gene mutations in lung adenocarcinoma.
Sun K; Zheng Y; Yang X; Jia W
Med Biol Eng Comput; 2024 May; 62(5):1427-1440. PubMed ID: 38233683
[TBL] [Abstract][Full Text] [Related]
5. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
Liu J; Lichtenberg T; Hoadley KA; Poisson LM; Lazar AJ; Cherniack AD; Kovatich AJ; Benz CC; Levine DA; Lee AV; Omberg L; Wolf DM; Shriver CD; Thorsson V; ; Hu H
Cell; 2018 Apr; 173(2):400-416.e11. PubMed ID: 29625055
[TBL] [Abstract][Full Text] [Related]
6. An uncommon atrioventricular block pattern associated with a novel mutation in TTN.
Wang GQ; Sun XJ; Zhong L
QJM; 2024 Apr; ():. PubMed ID: 38608183
[No Abstract] [Full Text] [Related]
7. Titin mutation associated with responsiveness to checkpoint blockades in solid tumors.
Jia Q; Wang J; He N; He J; Zhu B
JCI Insight; 2019 May; 4(10):. PubMed ID: 31092729
[TBL] [Abstract][Full Text] [Related]
8. MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan-cancer.
Yang Y; Zhang J; Chen Y; Xu R; Zhao Q; Guo W
Clin Transl Med; 2020 Aug; 10(4):e155. PubMed ID: 32898332
[No Abstract] [Full Text] [Related]
9. Spontaneous mutations in the single
Oh JH; Jang SJ; Kim J; Sohn I; Lee JY; Cho EJ; Chun SM; Sung CO
NPJ Genom Med; 2020; 5():33. PubMed ID: 32821429
[TBL] [Abstract][Full Text] [Related]
10. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.
Zheng QX; Wang J; Gu XY; Huang CH; Chen C; Hong M; Chen Z
Biomed Pharmacother; 2021 Mar; 135():111169. PubMed ID: 33433359
[TBL] [Abstract][Full Text] [Related]
11. TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival.
Freudenstein D; Litchfield C; Caramia F; Wright G; Solomon BJ; Ball D; Keam SP; Neeson P; Haupt Y; Haupt S
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545367
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
[TBL] [Abstract][Full Text] [Related]
13. Titin mutation in circulatory tumor DNA is associated with efficacy to immune checkpoint blockade in advanced non-small cell lung cancer.
Su C; Wang X; Zhou J; Zhao J; Zhou F; Zhao G; Xu X; Zou X; Zhu B; Jia Q
Transl Lung Cancer Res; 2021 Mar; 10(3):1256-1265. PubMed ID: 33889507
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of multiple microarray studies to identify potential pathogenic gene modules in preeclampsia.
Xu H; Xie Y; Sun Y; Guo R; Lv D; Li X; Li F; He M; Fan Y; Deng D
Exp Mol Pathol; 2021 Jun; 120():104631. PubMed ID: 33744280
[TBL] [Abstract][Full Text] [Related]
15. TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer.
Liu Z; Wang L; Guo C; Liu L; Jiao D; Sun Z; Wu K; Zhao Y; Han X
J Cell Mol Med; 2021 Apr; 25(7):3239-3251. PubMed ID: 33624434
[TBL] [Abstract][Full Text] [Related]
16. Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma.
Cai X; Chen Z; Deng M; Li Z; Wu Q; Wei J; Dai C; Wang G; Luo C
Ann Transl Med; 2020 Sep; 8(18):1176. PubMed ID: 33241025
[TBL] [Abstract][Full Text] [Related]
17. Integrated multi-omics data analyses for exploring the co-occurring and mutually exclusive gene alteration events in colorectal cancer.
Zhou Y; Cheng X; Zhang F; Chen Q; Chen X; Shen Y; Lai C; Kota VG; Sun W; Huang Q; Yuan Y; Wang J; Lai M; Zhang D
Hum Mutat; 2020 Sep; 41(9):1588-1599. PubMed ID: 32485022
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC).
Pérez Sayáns M; Chamorro Petronacci CM; Lorenzo Pouso AI; Padín Iruegas E; Blanco Carrión A; Suárez Peñaranda JM; García García A
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31703248
[TBL] [Abstract][Full Text] [Related]
19. Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients.
Wang Z; Wang C; Lin S; Yu X
Front Oncol; 2021; 11():725292. PubMed ID: 34513703
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
